SI-2 has been verified to significantly inhibit breast cancer growth through a direct interaction with SRC-3, as well as to selectively reduce protein concentrations and transcriptional activities of SRC-3 without greatly affected cellular viability31. This evidence concerns the gene NCOA3 and breast cancer.